Skip to content
    Domain Associates logo

    Domain Associates

    Princeton, New Jersey, United StatesFounded 1985
    domainvc.comLinkedIn
    Biotech & Life SciencesHealthcare

    Domain Associates is a venture capital firm with an exclusive focus on life sciences, investing in biopharmaceutical, medical device, diagnostic, and healthcare IT companies. Founded in 1985, the firm has managed over $2.8 billion in assets and backed more than 194 portfolio companies resulting in 90 IPOs and 110 M&A events.

    31% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $32.5M (across 153 rounds with reported amounts).

    Find people at Domain Associates on Goldilocks AI

    Portfolio

    98

    Fund Size

    $163.6M

    Top Stage

    Series B

    Last 12 Mo

    0

    Team

    LK

    Lisa Kraeutler

    Managing Director of Finance and Administration

    BD

    Brian Dovey

    Partner (In Memorium 2023)

    BH

    Brian Halak

    Partner

    DP

    Dennis Podlesak

    Venture Partner

    EW

    Eckard Weber

    Venture Partner

    JB

    James Blair

    Partner

    JT

    Jesse Treu

    Partner Emeritus

    KS

    Kathleen Schoemaker

    Partner and CFO (In Memorium 2016)

    KK

    Kim Kamdar

    Partner

    NV

    Nicole Vitullo

    Partner

    DL

    Debra Liebert

    Managing Director

    JB

    Jim Blair

    Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    167 investments
    CompanyRoundAmountDate
    Sera Prognostics logoSera PrognosticsSeries E$100MJan 2026
    RRevisionSeries D—Jan 2026
    AAntios Therapeutics, Inc.Series A$75MNov 2021
    AAxial TherapeuticsSeries C$37.3MOct 2021
    AAntios Therapeutics, Inc.Series B$96MApr 2021
    AAntios Therapeutics, Inc.Series B$96MJan 2021
    Exalys Therapeutics Inc. logoExalys Therapeutics Inc.Series A$15MJul 2020
    Aspen Neuroscience logoAspen NeuroscienceSeries A$70MApr 2020
    Omniome logoOmniomeSeries C$60MJan 2020
    Seraphina Therapeutics logoSeraphina TherapeuticsSeries A$5.5MJan 2020
    Aspen Neuroscience logoAspen NeuroscienceSeed$6.5MDec 2019
    Sera Prognostics logoSera PrognosticsSeries D$36MNov 2019
    Sera Prognostics logoSera PrognosticsSeries D$36MJan 2019
    Omniome logoOmniomeSeries B$60MJul 2018
    Omniome logoOmniomeSeries B$60MJan 2018
    Milestone Pharmaceuticals logoMilestone PharmaceuticalsSeries C$55MAug 2017
    Adynxx logoAdynxxSeries B$16MJan 2017
    Sera Prognostics logoSera PrognosticsSeries C$40MJan 2017
    ROX Medical logoROX MedicalSeries E$40MSep 2016
    Axial Biotherapeutics logoAxial BiotherapeuticsSeries A$19.1MJan 2016
    RRevisionUnknown$32MJan 2016
    Syndax Pharmaceuticals logoSyndax PharmaceuticalsSeries C$80MAug 2015
    Milestone Pharmaceuticals logoMilestone PharmaceuticalsSeries B$17MJun 2015
    Colucid Pharmaceuticals logoColucid PharmaceuticalsSeries C$37.1MJan 2015
    Syndax logoSyndaxSeries C$80MJan 2015
    Page 1 of 7

    Top Co-Investors

    InterWest Partners19 shared
    Canaan Partners18 shared
    Sofinnova Partners13 shared
    Frazier Healthcare Partners11 shared
    Pappas Capital11 shared
    OrbiMed10 shared
    Versant Ventures10 shared
    ARCH Venture Partners9 shared
    Hercules Capital, Inc.9 shared
    Novo Holdings A/S8 shared
    Forward Partners7 shared
    Cross Creek7 shared
    BDC Capital7 shared
    Scale Venture Partners7 shared
    New Enterprise Associates7 shared
    Deerfield6 shared
    Health Catalyst Capital6 shared
    MPM Capital6 shared
    Abingworth LLP6 shared
    Novo Capital6 shared

    Last updated: 20 October 2026